U.S. Physical Therapy Inc. Common Stock (USPH) fair value

ACCE thesis

U.S. Physical Therapy operates outpatient clinics that deliver physical therapy, occupational therapy and related rehabilitation services, with its own margin structure built around a clinic-level model and a growing set of workers' compensation and injury-care programs. Its moat is mostly local: density of clinics in its markets, referral relationships with physicians and employers, and the operating discipline to keep a large footprint profitable. Revenue growth of 8.5% and an 11.1% operating margin put it in a steady, not explosive, position, and a trailing P/E near 478 reflects depressed GAAP earnings rather than a stretched valuation, with the forward P/E of 27.2 giving a cleaner read on what the market expects. Return on equity of 6.5% is thin, so the case rests on whether margins recover and whether acquisitions and de novo clinic openings translate into earnings growth. The stock is not in any major index, which keeps coverage thin and may leave room for mispricing, but the 49/100 score signals the quantitative profile is weak enough that the case needs to be built from fundamentals before anything else.